Matches in DBpedia 2015-10 for { ?s ?p "Discovery and development of beta-adrenergic receptor antagonists β-adrenergic receptor antagonists (beta-blockers/β-blockers) were initially developed in the 1960s, for the treatment of angina pectoris but are now also used for hypertension, congestive heart failure and certain arrhythmias. In the 1950s, dichloroisoproterenol (DCI) was discovered to be a β-antagonist that blocked the effects of sympathomimetic amines on bronchodilation, uterine relaxation and heart stimulation. Although DCI had no clinical utility, a change in the compound did provide a clinical candidate, pronethalol, which was introduced in 1962."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Discovery_and_development_of_beta-adrenergic_receptor_antagonists_(beta-blockers) abstract "Discovery and development of beta-adrenergic receptor antagonists β-adrenergic receptor antagonists (beta-blockers/β-blockers) were initially developed in the 1960s, for the treatment of angina pectoris but are now also used for hypertension, congestive heart failure and certain arrhythmias. In the 1950s, dichloroisoproterenol (DCI) was discovered to be a β-antagonist that blocked the effects of sympathomimetic amines on bronchodilation, uterine relaxation and heart stimulation. Although DCI had no clinical utility, a change in the compound did provide a clinical candidate, pronethalol, which was introduced in 1962.".